Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +79.55% | +1,407.63% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 14.55 | 3.642 | 0.6344 |
Enterprise Value (EV) 1 | 14.55 | 3.642 | 0.6344 |
P/E ratio | -315 x | -62.5 x | -16 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | - |
EV / Revenue | - | - | - |
EV / EBITDA | - | - | - |
EV / FCF | - | - | - |
FCF Yield | - | - | - |
Price to Book | -250 x | -31.3 x | -4.06 x |
Nbr of stocks (in thousands) | 74,641 | 74,641 | 74,641 |
Reference price 2 | 0.1950 | 0.0488 | 0.008500 |
Announcement Date | 3/29/22 | 3/31/23 | 4/9/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales | - | - | - | - | - |
EBITDA | - | - | - | - | - |
EBIT 1 | -0.0244 | -0.0189 | -0.0463 | -0.0583 | -0.0397 |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.0242 | -0.0176 | -0.0463 | -0.0583 | -0.0397 |
Net income 1 | -0.0242 | -0.0176 | -0.0463 | -0.0583 | -0.0397 |
Net margin | - | - | - | - | - |
EPS 2 | -0.000656 | -0.000236 | -0.000619 | -0.000781 | -0.000532 |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 3/1/21 | 3/1/21 | 3/29/22 | 3/31/23 | 4/9/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | -186% | 154% | 70.9% | 30.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share 2 | 0 | -0 | -0 | -0 | -0 |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 3/1/21 | 3/1/21 | 3/29/22 | 3/31/23 | 4/9/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+1.80% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- HGYN Stock
- CERPQ Stock
- Financials CEREPLAST